Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-23-021201

Director sold 9,325 shares at $3.28 ($30,586)

  • Director acquired 9,682 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kiener Peter A Director 2023-03-23 Option exercise +9,682 $2.86 $27,691 9,682 D: show line 1 in the form
Kiener Peter A Director 2023-03-23 Sale −9,325 $3.28 $30,586 357 D: show line 2 in the form
Open-market sales · 9,325 sh · avg $3.28 · $30,586

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kiener Peter A Director 2023-03-23 Option exercise · Stock Option (right to buy) −9,682 96,062 D: show line 3 in the form
Loading xslF345X04/doc4.xml…